City Holding Co’s Alexion Pharmaceuticals ALXN Stock Holding History

City Holding Co’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-38	Closed	-$5K	–	518
2019 Q1	$5K	Hold	38	–	–	﹤0.01%	429
2018 Q4	$4K	Hold	38	–	–	﹤0.01%	433
2018 Q3	$5K	Hold	38	–	–	﹤0.01%	452
2018 Q2	$5K	Hold	38	–	–	﹤0.01%	452
2018 Q1	$4K	Hold	38	–	–	﹤0.01%	489
2017 Q4	$5K	Hold	38	–	–	﹤0.01%	476
2017 Q3	$5K	Hold	38	–	–	﹤0.01%	470
2017 Q2	$5K	Hold	38	–	–	﹤0.01%	474
2017 Q1	$5K	Hold	38	–	–	﹤0.01%	469
2016 Q4	$5K	Hold	38	–	–	﹤0.01%	448
2016 Q3	$5K	Hold	38	–	–	﹤0.01%	439
2016 Q2	$4K	Buy	+38	New	+$5.39K	﹤0.01%	475

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

City Holding Co's ALXN Position: Q2 2019 in Review

City Holding Co sold out of Alexion Pharmaceuticals (ALXN) in Q2 2019, closing a stake of 38 shares — an estimated $5K sold.

City Holding Co first reported a position in ALXN in Q2 2016 and held it in 12 quarters. The position peaked at $5K in Q1 2019. 636 funds tracked by Wall St. Rank hold ALXN as of Q2 2019.

City Holding Co reported no remaining Alexion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
City Holding Co sold 38 Alexion Pharmaceuticals shares in Q2 2019, an estimated $5K.
City Holding Co first reported a position in Alexion Pharmaceuticals in Q2 2016 and held it in 12 quarters.
City Holding Co's Alexion Pharmaceuticals position peaked at $5K in Q1 2019.
636 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2019.

Based on City Holding Co's 13F filing for Q2 2019, filed 16 Jul 2019.